Optas LLC’s Amgen AMGN Stock Holding History

Optas LLC’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$658K	Sell	1,817 -69	-4%	-$23.6K	0.09%	133
2026 Q1	$664K	Buy	1,886 +364	+24%	+$130K	0.1%	125
2025 Q4	$498K	Buy	1,522 +26	+2%	+$8.25K	0.08%	173
2025 Q3	$422K	Sell	1,496 -108	-7%	-$31.3K	0.07%	184
2025 Q2	$448K	Buy	1,604 +243	+18%	+$68.8K	0.09%	154
2025 Q1	$424K	Buy	1,361 +181	+15%	+$53.4K	0.07%	136
2024 Q4	$308K	Buy	1,180 +159	+16%	+$47.2K	0.07%	176
2024 Q3	$329K	Buy	1,021 +13	+1%	+$4.25K	0.08%	151
2024 Q2	$315K	Sell	1,008 -69	-6%	-$20.3K	0.08%	132
2024 Q1	$306K	Sell	1,077 -14	-1%	-$4.1K	0.08%	138
2023 Q4	$314K	Buy	1,091 +166	+18%	+$45.2K	0.09%	130
2023 Q3	$249K	Buy	+925	New	+$231K	0.08%	143
2023 Q1	–	Sell	-791	Closed	-$208K	–	164
2022 Q4	$208K	Buy	+791	New	+$212K	0.09%	132
2020 Q4	–	Sell	-1,236	Closed	-$314K	–	142
2020 Q3	$314K	Buy	+1,236	New	+$306K	0.1%	126

Other funds holding AMGN

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFM

Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

SMDAM

Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Optas LLC's AMGN Position: Q2 2026 in Review

Optas LLC reduced its Amgen (AMGN) stake by 3.7% in Q2 2026, selling an estimated $23.6K and leaving 1,817 shares worth $658K. The position accounts for 0.09% of the portfolio, ranked #133.

Optas LLC first reported a position in AMGN in Q3 2020 and has held it in 14 quarters since. The position peaked at $664K in Q1 2026. 937 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Optas LLC held 1,817 shares of Amgen worth $658K as of Q2 2026.
Optas LLC sold 69 Amgen shares in Q2 2026, an estimated $23.6K.
Amgen made up 0.09% of Optas LLC's portfolio in Q2 2026, its #133 holding.
Optas LLC first reported a position in Amgen in Q3 2020 and has held it in 14 quarters since.
Optas LLC's Amgen position peaked at $664K in Q1 2026.
937 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Optas LLC's 13F filing for Q2 2026, filed 21 Jul 2026.